Distribution of CFTR mutations in the Czech population: Positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populations
pmid: 23276700
Distribution of CFTR mutations in the Czech population: Positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populations
This two decade long study presents a comprehensive overview of the CFTR mutation distribution in a representative cohort of 600 Czech CF patients derived from all regions of the Czech Republic.We examined the most common CF-causing mutations using the Elucigene CF-EU2v1™ assay, followed by MLPA, mutation scanning and/or sequencing of the entire CFTR coding region and splice site junctions.We identified 99.5% of all mutations (1194/1200 CFTR alleles) in the Czech CF population. Altogether 91 different CFTR mutations, of which 20 were novel, were detected. One case of de novo mutation and a novel polymorphism was revealed.The commercial assay achieved 90.7%, the MLPA added 1.0% and sequencing increased the detection rate by 7.8%. These comprehensive data provide a basis for the improvement of CF DNA diagnostics and/or newborn screening in our country. In addition, they are relevant to related Central European populations with lower mutation detection rates, as well as to the sizeable North American "Bohemian diaspora".
- Humboldt-Universität zu Berlin Germany
- California State University System United States
- Humboldt State University United States
- Charles University Czech Republic
- University Hospital in Motol Czech Republic
Newborn screening, Pulmonary and Respiratory Medicine, Male, Central Europe, Clinical Laboratory Techniques, Cystic Fibrosis Transmembrane Conductance Regulator, De novo CFTR mutation, Cystic fibrosis, Child, Preschool, Mutation, Humans, Pediatrics, Perinatology, and Child Health, Child, Alleles, Czech Republic
Newborn screening, Pulmonary and Respiratory Medicine, Male, Central Europe, Clinical Laboratory Techniques, Cystic Fibrosis Transmembrane Conductance Regulator, De novo CFTR mutation, Cystic fibrosis, Child, Preschool, Mutation, Humans, Pediatrics, Perinatology, and Child Health, Child, Alleles, Czech Republic
64 Research products, page 1 of 7
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
chevron_left - 1
- 2
- 3
- 4
- 5
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).21 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
